Rob Pieters
MD, PhD
Chief Medical Officer
👥Biography 个人简介
Rob Pieters has led the Interfant international cooperative trials for infant KMT2A-rearranged (MLL-rearranged) acute lymphoblastic leukemia, defining standard treatment approaches for this highest-risk pediatric leukemia population. His work has characterized the distinct biology of infant MLL-rearranged ALL and informed emerging menin inhibitor strategies. He leads European pediatric oncology research at Princess Maxima.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Rob Pieters 的研究动态
Follow Rob Pieters's research updates
留下邮箱，当我们发布与 Rob Pieters（Princess Maxima Center for Pediatric Oncology）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment